-
Nov 27, 2015, 2:07 am64 ptsShkreli indicates no retreat from jacking up the price of a drug he bought by more than 5,000 percent. The price-gouging “pharma bro” is backing out of his promise to lower the cost of Daraprim after jacking up its price by more than 5,000 percent. Martin Shkreli, chief executive officer of…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.